0001662223-15-000002.txt : 20151231 0001662223-15-000002.hdr.sgml : 20151231 20151231133836 ACCESSION NUMBER: 0001662223-15-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20151231 DATE AS OF CHANGE: 20151231 EFFECTIVENESS DATE: 20151231 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Xios Therapeutics, Inc. CENTRAL INDEX KEY: 0001662223 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-254293 FILM NUMBER: 151315682 BUSINESS ADDRESS: STREET 1: C/O COOLEY LLP STREET 2: 500 BOYLSTON STREET CITY: BOSTON STATE: MA ZIP: 02116 BUSINESS PHONE: 617-937-2300 MAIL ADDRESS: STREET 1: C/O COOLEY LLP STREET 2: 500 BOYLSTON STREET CITY: BOSTON STATE: MA ZIP: 02116 D 1 primary_doc.xml X0707 D LIVE 0001662223 Xios Therapeutics, Inc. C/O COOLEY LLP 500 BOYLSTON STREET BOSTON MA MASSACHUSETTS 02116 617-937-2300 DELAWARE None None Corporation true 2015 Diala Ezzeddine c/o Xios Therapeutics, Inc. 500 Boylston Street, 14th Floor Boston MA MASSACHUSETTS 02116 Executive Officer Director Jeff Bird c/o Xios Therapeutics, Inc. 500 Boylston Street, 14th Floor Boston MA MASSACHUSETTS 02116 Director Rick Wagner c/o Xios Therapeutics, Inc. 500 Boylston Street, 14th Floor Boston MA MASSACHUSETTS 02116 Director Other Decline to Disclose 06b false 2015-12-17 false true false 0 6000000 6000000 0 false 27 0 0 0 false Xios Therapeutics, Inc. /s/ Diala Ezzeddine Diala Ezzeddine CEO 2015-12-31